Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$850,520
-$26,256 QoQ
Shares Held
6,732
+7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,147
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Certified Advisory Corp holds $12,736,081 across 8 Drug Manufacturers - General names. GILD ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,212 | $4,117,361 | |
| 2 | LLY |
ELI LILLY & Co
|
3,249 | $3,896,948 | |
| 3 | ABBV |
AbbVie Inc.
|
7,683 | $1,933,350 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
6,732 | $850,520 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,383 | $820,215 | |
| 6 | AMGN |
Amgen Inc
|
1,762 | $638,055 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,692 | $270,353 | |
| 8 | PFE |
Pfizer Inc
|
8,691 | $209,279 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $850,520 | 6,732 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $876,776 | 6,291 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $860,161 | 7,008 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,132,644 | 10,204 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,131,095 | 10,202 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,139,212 | 10,167 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $966,559 | 10,464 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $878,391 | 10,477 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $734,058 | 10,699 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $823,916 | 11,248 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $922,055 | 11,382 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $870,202 | 11,612 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $940,638 | 12,205 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,024,430 | 12,347 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $1,059,216 | 12,338 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $761,870 | 12,350 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $875,043 | 14,157 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $840,443 | 14,137 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,017,192 | 14,009 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $998,645 | 14,297 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $973,404 | 14,136 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $924,790 | 14,309 | Shares | Defined | 2021-05-10 | |
| 2020-06-30 | $1,142,558 | 14,850 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $1,100,840 | 14,725 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||